Thus, CB1 antagonism as an add-on therapy in DMD might also result in the sparing of steroidal anti-inflammatory drugs, which are responsible for serious side effects in children affected by this disease53. The gene discussed is CNR1; the disease is Duchenne muscular dystrophy.